Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

Current Biology

Volumn 13, Issue 19, 2003, Pages 1721-1727

  Bates, Richard C ^a   Goldsmith, Jeffrey D ^a   Bachelder, Robin E ^a   Brown, Courtney ^a   Shibuya, Masabumi ^b   Oettgen, Peter ^a   Mercurio, Arthur M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141838134     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2003.09.002     Document Type: Article

References (36)

1. Jaattela, M. (1999). Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248, 30-43.
2. Bates, R.C., and Mercurio, A.M. (2003). Tumor necrosis factor-α stimulates the epithelial to mesenchymal transition of human colonic organoids. Mol. Biol. Cell 14, 1790-1800.
3. Oft, M., Pili, J., Rudaz, C., Schwarz, H., Beug, H., and Reichmann, E. (1996). TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477.
4. Oft, M., Heider, K.H., and Berg, H. (1998). TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, 1243-1252.
5. Bhowmick, N.A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C.A., Engel, M.E., Artega, C.L., and Moses, H.L. (2001). Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a Rho-A-dependent mechanism. Mol. Biol. Cell 12, 27-36.
6. Hay, E.D. (1995). An overview of the epithelio-mesenchymal transformation. Acta Anat. 154, 8-20.
7. Savagner, P. (2001). Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23, 912-923.
8. Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
9. Whitehead, R.H., Jones, J.K., Gabriel, A., and Lukies, R.E. (1987). A new colon carcinoma cell line (LIM 1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res. 47, 2683-2689.
10. Bates, R.C., Buret, A., van Helden, D.F., Horton, M.A., and Burns, G.F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
11. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C.H. (1994). Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
12. Korpelainen, E.I., and Alitalo, K. (1998). Signaling angiogenesis and lymphangiogenesis. Curr. Opin. Cell Biol. 10, 159-164.
13. Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., and Shibuya, M. (2001). Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res. 61, 1207-1213.
14. Park, J.E., Chen, H.H., Winer, J., Houck, K.A., and Ferrara, N. (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25646-25654.
15. von Marschall, Z., Cramer, T., Hocker, M., Burde, R., Plath, T., Schirner, M., Heindrich, R., Breier, G., Riecken, E.O., Wiedenmann, B., et al. (2000). De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology 119, 1358-1372.
16. Soker, S., Kaefer, M., Johnson, M., Klagsbrun, M., Atala, A., and Freeman, M.R. (2001). Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am. J. Pathol. 159, 651-659.
17. Fakhari, M., Pullirsch, D., Paya, K., Abraham, D., Hofbauer, R., and Aharinejad, S. (2002). Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. J. Pediatr. Surg. 37, 582-587.
18. Wakiya, K., Begue, A., Stehelin, D., and Shibuya, M. (1996). A cAMP response element and an Ets motif are involved in the transcriptional regulation of the flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J. Biol. Chem. 271, 30823-30828.
19. Dube, A., Akbarali, Y., Sato, T.N., Libermann, T.A., and Oettgen, P. (1999). Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ. Res, 84, 1177-1185.
20. Brekken, R.A., Overholser, J.P., Stastny, V.A., Walteneberger, J., Minna, J.D., and Thorpe, P.E. (2000). Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res, 60, 5117-5124.
21. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., and Shibuya, M. (2001). Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97, 785-791.
22. Kuo, C.J., Farnebo, F., Yu, E.Y., Christofferson, R., Swearingen, R.A., Carter, R., von Recum, H.A., Yuan, J., Kamihara, J., Flynn, E., et al. (2001). Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc. Natl. Acad. Sci. USA 98, 4606-4610.
23. Chen, T.R., Hay, R.J., and Macy, M.L. (1983). Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet. Cytogenet. 10, 351-362.
24. Strizzi, L., Catalano, A., Vianale, G., Orecchia, S., Casalini, A., Tassi, G., Puntoni, R., Mutti, L., and Procopio, A. (2001). Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol. 193, 468-475.
25. Gerber, H.-P., Malik, A.K., Solar, G.P., Sherman, D., Liang, X.H., Meng, G., Hong, K., Marsters, J.C., and Ferrara, N. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954-958.
26. Broggini, M., Marchini, S.V., Galliera, E., Borsotti, P., Taraboletti, G., Erba, E., Sironi, M., Jimeno, J., Faircloth, G.T., Giavazzi, R., et al. (2003). Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells Molt-4. Leukemia 17, 52-59.
27. Grosskreutz, C.L., Anand-Apte, B., Duplaa, C., Quinn, T.P., Terman, B.I., Zetter, B., and D'Amore, P.A. (1999). Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc. Res. 58, 128-136.
28. Ishida, A., Murray, J., Saito, Y., Kanthou, C., Benzakour, O., Shibuya, M., and Wijelath, E.S. (2001). Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell. Physiol. 188, 359-368.
29. Andre, T., Kotelevets, L., Vaillant, J.C., Coudray, A.M., Weber, L., Prevot, S., Parc, R., Gespach, C., and Chastre, E. (2000). Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int. J. Cancer 86, 174-181.
30. Warren, R.S., Yuan, H., Matli, M.R., Gillett, N.A., and Ferrara, N. (1995). Regulation by vascular enothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789-1797.
31. Mahasreshti, P.J., Navarro, J.G., Kataram, M., Wang, M.H., Carey, D., Siegal, G.P., Barnes, M.N., Nettelbeck, D.M., Alvarez, R.D., Hemminki, A., et al. (2001). Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. Clin. Cancer Res. 7, 2057-2066.
32. Hasumi, Y., Mizukami, H., Urabe, M., Kohno, T., Takeuchi, K., Kume, A., Momoeda, M., Yoshikawa, H., Tsuruo, T., Shibuya, M., et al. (2002). Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Cancer Res. 62, 2019-2023.
33. Hoshida, T., Sunamura, M., Duda, D.G., Egawa, S., Miyazaki, S., Shineha, R., Hamada, H., Ohtani, H., Satomi, S., and Matsuno, S. (2002). Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Pancreas 25, 111-121.
34. Yang, W., Arii, S., Mori, A., Furumoto, K., Nakao, T., Isobe, N., Murata, T., Onodera, H., and Imamura, M. (2001). sFlt-1 gene-transfected fibroblasts: a wound specific gene therapy inhibits local cancer recurrence. Cancer Res. 61, 7840-7845.
35. Takayama, KK., Ueno, H., Nakanishi, Y., Sakamoto, T., Inoue, K., Shimizu, K., Oohashi, H., and Hara, N. (2000). Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res. 60, 2169-2177.
36. Manley, P.W., Martiny-Baron, G., Schlaeppi, J.-M., and Wood, J.M. (2002). Therapies directed at vascular endothelial growth factor. Expert Opin. Investig. Drugs 11, 1715-1736.